Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term
The purpose of this study is to determine whether induction of labor with vaginal misoprostol application will result in fewer cesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at term...
Brief Summary
Official Title: “Comparison of Misoprostol and PGE2 Gel for Induction of Labour in in Premature Rupture of Membranes at Term- A Randomized Comparative Trial”
The purpose of this study is to determine whether induction of labor with vaginal misoprostol application will result in fewer cesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at term.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
- Study Primary Completion Date: August 2012
Intervention(s) in this Clinical Trial
- Drug: Misoprostol
- Vaginal application of Misoprostol tablets at 4 hrly interval with maximumof five doses
- Drug: PGE2 gel
- PGE2 gel will be applied in poaterior fornix at six hrly interval with maximum of 2 doses
Arms, Groups and Cohorts in this Clinical Trial
- Active Comparator: Misoprostol tablet, PGE2 gel
- participants are assigned to one of two arms for the duration of the study In one group induction of labour is done by intravaginal misoprostol tablets at 4 hrly interval with maximum of five doses.In other group PGE2 gel is applied in poaterior fornix at six hourly interval.
Outcome Measures for this Clinical Trial
Primary Measures
- Caesarean Section rate
- Time Frame: 48 hours
Safety Issue?: No
- Time Frame: 48 hours
Secondary Measures
- Induction delivery time
- Time Frame: 48 hours
Safety Issue?: No
- Time Frame: 48 hours
- Neonatal & maternal infectious morbidity
- Time Frame: 14 days following date of delivery
Safety Issue?: No
- Time Frame: 14 days following date of delivery
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Premature rupture of membranes at 37 or more weeks
- Single live fetus in cephalic presentation
Exclusion Criteria:
- Women in labour
- Women with contraindication of induction of labour
- Women with previous caesarean section or uterine surgery
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Nilratan Sircar Medical College Other
Overall Clinical Trial Officials and Contacts
Snehamay Chaudhuri, MBBS,MD.DNB Principal Investigator Nilratan Sircar Medical College , Kolkata, West bengal , India
Overall Contact: Snehamay Chaudhuri, MBBS,MD,DNB 91-33-23537900 snehamay_chaudhuri_dr@yahoo.com
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00355303
Study ID Number: 2-Chaudhuri
ClinicalTrials.gov Identifier: NCT00355303
Health Authority: India: Ministry of Health
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00355303
